287 related articles for article (PubMed ID: 23175273)
41. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.
Le Vee M; Gripon P; Stieger B; Fardel O
Drug Metab Dispos; 2008 Feb; 36(2):217-22. PubMed ID: 17991769
[TBL] [Abstract][Full Text] [Related]
42. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice.
Lam P; Wang R; Ling V
Biochemistry; 2005 Sep; 44(37):12598-605. PubMed ID: 16156672
[TBL] [Abstract][Full Text] [Related]
43. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability.
Hendriks DF; Fredriksson Puigvert L; Messner S; Mortiz W; Ingelman-Sundberg M
Sci Rep; 2016 Oct; 6():35434. PubMed ID: 27759057
[TBL] [Abstract][Full Text] [Related]
44. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process.
Elferink MG; Olinga P; Draaisma AL; Merema MT; Faber KN; Slooff MJ; Meijer DK; Groothuis GM
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1008-16. PubMed ID: 15205115
[TBL] [Abstract][Full Text] [Related]
45. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
[TBL] [Abstract][Full Text] [Related]
46. Hepatobiliary transporter expression in human hepatocellular carcinoma.
Zollner G; Wagner M; Fickert P; Silbert D; Fuchsbichler A; Zatloukal K; Denk H; Trauner M
Liver Int; 2005 Apr; 25(2):367-79. PubMed ID: 15780063
[TBL] [Abstract][Full Text] [Related]
47. Short-term feedback regulation of bile salt uptake by bile salts in rodent liver.
Mühlfeld S; Domanova O; Berlage T; Stross C; Helmer A; Keitel V; Häussinger D; Kubitz R
Hepatology; 2012 Dec; 56(6):2387-97. PubMed ID: 22806967
[TBL] [Abstract][Full Text] [Related]
48. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.
Keitel V; Vogt C; Häussinger D; Kubitz R
Gastroenterology; 2006 Aug; 131(2):624-9. PubMed ID: 16890614
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
50. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
[TBL] [Abstract][Full Text] [Related]
51. Ca(2+)-dependent protein kinase C isoforms are critical to estradiol 17beta-D-glucuronide-induced cholestasis in the rat.
Crocenzi FA; Sánchez Pozzi EJ; Ruiz ML; Zucchetti AE; Roma MG; Mottino AD; Vore M
Hepatology; 2008 Dec; 48(6):1885-95. PubMed ID: 18972403
[TBL] [Abstract][Full Text] [Related]
52. Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.
Yang Q; Yang F; Tang X; Ding L; Xu Y; Xiong Y; Wang Z; Yang L
BMC Complement Altern Med; 2015 Apr; 15():122. PubMed ID: 25887351
[TBL] [Abstract][Full Text] [Related]
53. Hepatobiliary transport.
Kullak-Ublick GA; Beuers U; Paumgartner G
J Hepatol; 2000; 32(1 Suppl):3-18. PubMed ID: 10728790
[TBL] [Abstract][Full Text] [Related]
54. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
Wang L; Wu G; Wu F; Jiang N; Lin Y
J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
[TBL] [Abstract][Full Text] [Related]
55. Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.
Petrov PD; Fernández-Murga L; Conde I; Martínez-Sena T; Guzmán C; Castell JV; Jover R
Arch Toxicol; 2020 Feb; 94(2):589-607. PubMed ID: 31894354
[TBL] [Abstract][Full Text] [Related]
56. Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2.
Donner MG; Schumacher S; Warskulat U; Heinemann J; Häussinger D
Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1134-46. PubMed ID: 17916651
[TBL] [Abstract][Full Text] [Related]
57. Hepatobiliary transport of bile acids and organic anions.
Takikawa H
J Hepatobiliary Pancreat Surg; 2002; 9(4):443-7. PubMed ID: 12483266
[TBL] [Abstract][Full Text] [Related]
58. The bile salt export pump: molecular properties, function and regulation.
Arrese M; Ananthanarayanan M
Pflugers Arch; 2004 Nov; 449(2):123-31. PubMed ID: 15578267
[TBL] [Abstract][Full Text] [Related]
59. Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membrane in MDCK II cells.
Kagawa T; Orii R; Hirose S; Arase Y; Shiraishi K; Mizutani A; Tsukamoto H; Mine T
J Gastroenterol; 2014 May; 49(5):890-9. PubMed ID: 23722250
[TBL] [Abstract][Full Text] [Related]
60. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
